1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 207 F.Supp.2d
  5. 207 F.Supp.2d 322 (2002)
 

NOVO NORDISK A/S v. BIO-TECHNOLOGY GENERAL CORP.

No. Civ.A.02-332-SLR.

207 F.Supp.2d 322 (2002)

NOVO NORDISK A/S and Novo Nordisk Pharmaceuticals, Inc., Plaintiffs, v. BIO-TECHNOLOGY GENERAL CORP., LTD. and Teva Pharmaceuticals USA, Inc., Defendants.

United States District Court, D. Delaware.

June 7, 2002.

Attorney(s) appearing for the Case

Richard D. Kirk, and Edward M. McNally of Morris, James, Hitchens & Williams LLP, Wilmington, DE, for Plaintiffs. Albert L. Jacobs, Jr., Daniel A. Ladow, Gerard F. Diebner, and Brad S. Needleman, of Greenberg Traurig, LLP, New York City, of counsel.

Josy W. Ingersoll of Young Conaway Stargatt & Taylor, LLP, Wilmington, DE, for Defendants. Richard L. DeLucia, Steven J. Lee, and Charles A. Weiss, of Kenyon & Kenyon, New York City, of counsel.

MEMORANDUM OPINION

SUE L. ROBINSON, Chief Judge.

I. INTRODUCTION

In this patent infringement suit, plaintiffs Novo Nordisk Pharmaceuticals, Inc. and Novo Nordisk A/S (collectively, "Novo") have accused defendants Bio-Technology General Corp. ("BTG") and Teva Pharmaceuticals USA, Inc. ("Teva") of infringing United States Patent No. 5,633,352 ("the '352 patent") through their activities involving Tev-TropinTM brand human...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases